Structural basis of tyrosine sulfation and VH-gene usage in antibodies that recognize the HIV type 1 coreceptor-binding site on gp120.
暂无分享,去创建一个
Wayne A Hendrickson | Peter D Kwong | Joseph Sodroski | Shahzad Majeed | Chih-chin Huang | J. Sodroski | R. Wyatt | D. Dimitrov | M. Venturi | W. Hendrickson | P. Kwong | S. Majeed | James E. Robinson | M. Farzan | H. Choe | S. Phogat | M. J. Moore | Mei-Yun Zhang | Miro Venturi | Michael J Moore | Hyeryun Choe | Michael Farzan | Sanjay Phogat | Richard Wyatt | Dimiter S Dimitrov | Mei-Yun Zhang | James Robinson | Chih‐chin Huang
[1] Martin A. Nowak,et al. Antibody neutralization and escape by HIV-1 , 2003, Nature.
[2] S. Rybak,et al. Broadly cross-reactive HIV neutralizing human monoclonal antibody Fab selected by sequential antigen panning of a phage display library. , 2003, Journal of immunological methods.
[3] J. Farber,et al. Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. , 1999, Annual review of immunology.
[4] C. MacKenzie,et al. Germline antibody recognition of distinct carbohydrate epitopes , 2003, Nature Structural Biology.
[5] Amos Bairoch,et al. The Sulfinator: predicting tyrosine sulfation sites in protein sequences , 2002, Bioinform..
[6] Peter D. Kwong,et al. The antigenic structure of the HIV gp120 envelope glycoprotein , 1998, Nature.
[7] L. Eckler,et al. Epitopes recognized by the neutralizing antibodies of an HIV-1-infected individual. , 1990, Journal of immunology.
[8] Garrett M. Morris,et al. Crystal Structure of a Neutralizing Human IgG Against HIV-1: A Template for Vaccine Design , 2001, Science.
[9] Marie-Paule Lefranc,et al. IMGT, the international ImMunoGeneTics database , 2001, Nucleic Acids Res..
[10] Christoph Grundner,et al. Tyrosine Sulfation of Human Antibodies Contributes to Recognition of the CCR5 Binding Region of HIV-1 gp120 , 2003, Cell.
[11] D E McRee,et al. XtalView/Xfit--A versatile program for manipulating atomic coordinates and electron density. , 1999, Journal of structural biology.
[12] S W Lin,et al. Specific interaction of CCR5 amino-terminal domain peptides containing sulfotyrosines with HIV-1 envelope glycoprotein gp120. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[13] M. Goldsmith,et al. Multiple Extracellular Elements of CCR5 and HIV-1 Entry: Dissociation from Response to Chemokines , 1996, Science.
[14] Ping Zhu,et al. Antibody Domain Exchange Is an Immunological Solution to Carbohydrate Cluster Recognition , 2003, Science.
[15] Marc Parmentier,et al. Regions in β-Chemokine Receptors CCR5 and CCR2b That Determine HIV-1 Cofactor Specificity , 1996, Cell.
[16] Peter D. Kwong,et al. HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites , 2002, Nature.
[17] M. Greaves,et al. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus , 1984, Nature.
[18] P. Sharp,et al. Origins and evolution of AIDS viruses: estimating the time-scale. , 2000, Biochemical Society transactions.
[19] R. Doms,et al. Two distinct CCR5 domains can mediate coreceptor usage by human immunodeficiency virus type 1 , 1997, Journal of virology.
[20] Joseph Sodroski,et al. Tyrosine Sulfation of the Amino Terminus of CCR5 Facilitates HIV-1 Entry , 1999, Cell.
[21] J. Sodroski,et al. HIV-1 Entry and Macrophage Inflammatory Protein-1β-mediated Signaling Are Independent Functions of the Chemokine Receptor CCR5* , 1997, The Journal of Biological Chemistry.
[22] K. Moore. The Biology and Enzymology of Protein Tyrosine O-Sulfation* , 2003, Journal of Biological Chemistry.
[23] E. Rosenberg,et al. Neutralizing Antibodies Associated with Viremia Control in a Subset of Individuals after Treatment of Acute Human Immunodeficiency Virus Type 1 Infection , 2001, Journal of Virology.
[24] J. Sodroski,et al. Probability Analysis of Variational Crystallization and Its Application to gp120, The Exterior Envelope Glycoprotein of Type 1 Human Immunodeficiency Virus (HIV-1)* , 1999, The Journal of Biological Chemistry.
[25] B. Haynes,et al. Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. , 1984, Science.
[26] Luc Montagnier,et al. T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV , 1984, Nature.
[27] J. Sodroski,et al. Characterization of conserved human immunodeficiency virus type 1 gp120 neutralization epitopes exposed upon gp120-CD4 binding , 1993, Journal of virology.
[28] J. Chermann,et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). , 1983, Science.
[29] Joseph Sodroski,et al. Characterization of CD4-induced epitopes on the HIV type 1 gp120 envelope glycoprotein recognized by neutralizing human monoclonal antibodies. , 2002, AIDS research and human retroviruses.
[30] J. Sodroski,et al. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody , 1998, Nature.
[31] G. Quinnan,,et al. Preparation and characterization of human HIV type 1 neutralizing reference sera. , 1995, AIDS research and human retroviruses.
[32] E A Merritt,et al. Raster3D: photorealistic molecular graphics. , 1997, Methods in enzymology.
[33] F. Quiocho. Atomic basis of the exquisite specificity of phosphate and sulfate transport receptors. , 1996, Kidney international.
[34] W A Hendrickson,et al. Structures of HIV-1 gp120 envelope glycoproteins from laboratory-adapted and primary isolates. , 2000, Structure.
[35] K. Sharp,et al. Protein folding and association: Insights from the interfacial and thermodynamic properties of hydrocarbons , 1991, Proteins.
[36] E. Myers,et al. Basic local alignment search tool. , 1990, Journal of molecular biology.
[37] Christoph Grundner,et al. Access of Antibody Molecules to the Conserved Coreceptor Binding Site on Glycoprotein gp120 Is Sterically Restricted on Primary Human Immunodeficiency Virus Type 1 , 2003, Journal of Virology.